RHYTHM PHARMACEUTICALS INC

Rhythm Pharma Executives Unite in Massive Insider Buy‑In, Betting Big on 2027 Obesity Trial Results

Insider buying spree at Rhythm Pharmaceuticals shows execs betting on upcoming obesity‑drug milestones, offering upside potential despite current losses.

RHYTHM PHARMACEUTICALS INC
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

14/02/2026, 00:28

4 minutes to read

CFO’s Planned Sell‑Off at Rhythm Pharmaceuticals Raises Flag Over Uncertain Pipeline and Profitability【News Flash】

Insider CFO sells 4,631 Rhythm shares—plan‑based move amid 52‑week highs, negative earnings, and uncertain pipeline milestones.

RHYTHM PHARMACEUTICALS INC
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

07/02/2026, 00:54

3 minutes to read

Newer articles